Mandatory Nodal Evaluation During Resection of Clinical T1a Non-Small Cell Lung Cancers

Submitted by: Christopher Anderson

Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2021.06.078

Keywords:

Author(s): Aaron R. Dezube, MD Emanuele Mazzola, PhD Ashley Deeb, MD Daniel C. Wiener, MD M. Blair Marshall, MD Mathew W. Rochefort, MD Michael T. Jaklitsch, MD

Recommendations for intraoperative lymph node evaluation are uniform regardless of whether a primary tumor is clinical T1a or T2a according to TNM 8th edition for stage I non-small cell lung cancer (NSCLC). We quantified nodal disease risk in patients with T1a disease (≤1 cm).

Add Comments

ADD TO PLAYLIST

Related Content